Recruiting Diffuse Large B-Cell Lymphoma Studies in St Louis
About Diffuse Large B-Cell Lymphoma Clinical Trials in St Louis
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, accounting for about 30% of cases. It is an aggressive lymphoma that grows rapidly. Treatment usually involves chemoimmunotherapy, with CAR-T cell therapy for relapsed cases.
There are currently 1 diffuse large b-cell lymphoma clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 70 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diffuse Large B-Cell Lymphoma Clinical Trials in St Louis — FAQ
Are there diffuse large b-cell lymphoma clinical trials in St Louis?
Yes, there are 1 diffuse large b-cell lymphoma clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in St Louis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.
Are clinical trials in St Louis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.
What diffuse large b-cell lymphoma treatments are being tested?
The 1 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for diffuse large b-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov